Lotus Historical Income Statement

600186 Stock

5.30 0.05 0.95%

Historical analysis of Lotus Health income statement accounts such as Selling General Administrative of 145.4 M, Total Revenue of 2 B or Operating Income of 193.8 M can show how well Lotus Health Group performed in making a profits. Evaluating Lotus Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Lotus Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Lotus Health Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lotus Health Group is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lotus Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Lotus Income Statement Analysis

Lotus Health Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Lotus Health shareholders. The income statement also shows Lotus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Lotus Health Income Statement Chart

At present, Lotus Health's Selling General Administrative is projected to decrease significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 193.8 M, whereas Interest Expense is forecasted to decline to about 534.9 K.

Selling General Administrative Total Revenue Minority Interest Research Development

Total Revenue

Total revenue comprises all receipts Lotus Health Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Lotus Health Group whose combined shares represent less than 50% of the total outstanding shares issued by Lotus Health have a minority interest in Lotus Health.

Most accounts from Lotus Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Lotus Health Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lotus Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	223.4M	238.6M	360.2M	233.3M
Research Development	22.1M	21.6M	28.7M	15.4M

Gross Profit Research Development

Lotus Health income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Minority Interest	Research Development	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Total Operating Expenses	Total Other Income Expense Net	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		0.61	-0.96	0.7	-0.45	-0.4	-0.94	-0.14	-0.57	-0.71	0.57	-0.72	-0.77	0.75	0.26	-0.4	-0.57	-0.23	-0.33	0.66
Total Revenue	0.61		-0.61	0.98	0.07	0.08	-0.68	0.12	-0.07	-0.24	0.16	-0.3	-0.35	0.37	0.09	-0.03	-0.07	0.19	-0.06	0.25
Operating Income	-0.96	-0.61		-0.72	0.47	0.43	0.94	0.19	0.6	0.75	-0.57	0.75	0.75	-0.75	-0.3	0.57	0.66	0.34	0.4	-0.68
Cost Of Revenue	0.7	0.98	-0.72		-0.09	-0.07	-0.74	0.02	-0.17	-0.32	0.23	-0.35	-0.38	0.4	0.13	-0.14	-0.18	0.07	-0.13	0.31
Income Before Tax	-0.45	0.07	0.47	-0.09		0.99	0.37	0.25	0.36	0.32	-0.36	0.38	0.27	-0.26	-0.09	0.44	0.38	0.34	0.49	-0.35
Net Income	-0.4	0.08	0.43	-0.07	0.99		0.32	0.29	0.35	0.28	-0.37	0.38	0.24	-0.22	-0.03	0.47	0.37	0.38	0.58	-0.33
Income Tax Expense	-0.94	-0.68	0.94	-0.74	0.37	0.32		-0.06	0.4	0.71	-0.46	0.76	0.8	-0.79	-0.21	0.43	0.48	0.1	0.28	-0.59
Minority Interest	-0.14	0.12	0.19	0.02	0.25	0.29	-0.06		0.46	0.0	-0.26	-0.02	-0.08	0.13	0.0	0.15	0.45	0.81	0.19	-0.07
Research Development	-0.57	-0.07	0.6	-0.17	0.36	0.35	0.4	0.46		0.79	-0.88	0.66	0.6	-0.59	-0.55	0.7	0.9	0.68	0.62	-0.85
Gross Profit	-0.71	-0.24	0.75	-0.32	0.32	0.28	0.71	0.0	0.79		-0.72	0.9	0.9	-0.86	-0.37	0.74	0.8	0.42	0.51	-0.83
Other Operating Expenses	0.57	0.16	-0.57	0.23	-0.36	-0.37	-0.46	-0.26	-0.88	-0.72		-0.7	-0.62	0.64	0.65	-0.7	-0.84	-0.43	-0.64	0.92
Net Income From Continuing Ops	-0.72	-0.3	0.75	-0.35	0.38	0.38	0.76	-0.02	0.66	0.9	-0.7		0.96	-0.93	-0.24	0.74	0.74	0.37	0.63	-0.82
Ebit	-0.77	-0.35	0.75	-0.38	0.27	0.24	0.8	-0.08	0.6	0.9	-0.62	0.96		-0.96	-0.18	0.57	0.67	0.28	0.41	-0.75
Total Operating Expenses	0.75	0.37	-0.75	0.4	-0.26	-0.22	-0.79	0.13	-0.59	-0.86	0.64	-0.93	-0.96		0.36	-0.61	-0.71	-0.24	-0.43	0.82
Total Other Income Expense Net	0.26	0.09	-0.3	0.13	-0.09	-0.03	-0.21	0.0	-0.55	-0.37	0.65	-0.24	-0.18	0.36		-0.45	-0.55	-0.07	-0.28	0.69
Tax Provision	-0.4	-0.03	0.57	-0.14	0.44	0.47	0.43	0.15	0.7	0.74	-0.7	0.74	0.57	-0.61	-0.45		0.83	0.59	0.76	-0.75
Net Interest Income	-0.57	-0.07	0.66	-0.18	0.38	0.37	0.48	0.45	0.9	0.8	-0.84	0.74	0.67	-0.71	-0.55	0.83		0.76	0.59	-0.84
Interest Income	-0.23	0.19	0.34	0.07	0.34	0.38	0.1	0.81	0.68	0.42	-0.43	0.37	0.28	-0.24	-0.07	0.59	0.76		0.47	-0.35
Ebitda	-0.33	-0.06	0.4	-0.13	0.49	0.58	0.28	0.19	0.62	0.51	-0.64	0.63	0.41	-0.43	-0.28	0.76	0.59	0.47		-0.67
Reconciled Depreciation	0.66	0.25	-0.68	0.31	-0.35	-0.33	-0.59	-0.07	-0.85	-0.83	0.92	-0.82	-0.75	0.82	0.69	-0.75	-0.84	-0.35	-0.67

Click cells to compare fundamentals

Lotus Health Account Relationship Matchups

Lotus Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	41.9M	21.8M	19.4M	5.1M	563.0K	534.9K
Selling General Administrative	184.0M	105.8M	92.0M	80.0M	122.3M	145.4M
Total Revenue	1.7B	1.7B	1.8B	1.7B	2.1B	2.0B
Operating Income	(243.9M)	123.1M	65.9M	75.7M	184.5M	193.8M
Cost Of Revenue	1.5B	1.4B	1.6B	1.5B	1.7B	1.7B
Income Before Tax	50.9M	104.1M	53.7M	60.4M	170.8M	179.3M
Net Income Applicable To Common Shares	(332.5M)	69.2M	74.3M	44.4M	39.9M	41.9M
Net Income	69.2M	74.3M	44.4M	46.2M	129.9M	136.4M
Income Tax Expense	(5.6M)	22.8M	27.1M	10.8M	9.7M	10.2M
Minority Interest	(237.4M)	(234.3M)	1.4M	(809.5K)	(752.4K)	(790.0K)
Gross Profit	172.9M	294.8M	223.4M	238.6M	360.2M	233.3M
Other Operating Expenses	12.9M	9.5M	8.7M	6.6M	5.9M	9.4M
Net Income From Continuing Ops	28.1M	76.9M	42.9M	47.0M	130.7M	137.2M
Ebit	(206.1M)	(209.8M)	113.2M	65.9M	75.7M	79.5M
Total Operating Expenses	1.9B	1.5B	1.7B	1.6B	1.9B	1.5B
Tax Provision	22.8M	27.1M	10.8M	13.4M	40.1M	42.1M
Net Interest Income	(34.9M)	(16.6M)	(8.6M)	8.5M	19.9M	20.9M
Interest Income	107.3K	5.8M	11.5M	16.7M	21.0M	22.1M
Ebitda	118.5M	137.3M	84.5M	83.8M	96.4M	101.2M
Reconciled Depreciation	25.7M	11.4M	11.4M	18.3M	18.1M	19.5M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Lotus Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lotus Historical Income Statement

About Lotus Income Statement Analysis

Lotus Health Income Statement Chart

Total Revenue

Minority Interest

Lotus Health income statement Correlations

Lotus Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lotus Health income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Lotus Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 0.99	Income Before Tax
Cost Of Revenue	+ 0.98	Total Revenue
Ebit	+ 0.96	Net Income From Continuing Ops
Income Tax Expense	+ 0.94	Operating Income
Reconciled Depreciation	+ 0.92	Other Operating Expenses
Net Interest Income	+ 0.9	Research Development

Total Operating Expenses	- 0.96	Ebit
Operating Income	- 0.96	Selling General Administrative
Income Tax Expense	- 0.94	Selling General Administrative
Total Operating Expenses	- 0.93	Net Income From Continuing Ops
Other Operating Expenses	- 0.88	Research Development
Total Operating Expenses	- 0.86	Gross Profit